NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 239 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $0 | -100.0% | 34 | -99.3% | 0.00% | -100.0% |
Q2 2022 | $19,000 | – | 4,946 | +10891.1% | 0.00% | – |
Q1 2022 | $0 | -100.0% | 45 | -40.0% | 0.00% | – |
Q4 2021 | $1,000 | -94.1% | 75 | -91.9% | 0.00% | -100.0% |
Q3 2021 | $17,000 | -19.0% | 926 | -25.7% | 0.00% | 0.0% |
Q2 2021 | $21,000 | +16.7% | 1,247 | +34.8% | 0.00% | 0.0% |
Q1 2021 | $18,000 | -50.0% | 925 | -55.5% | 0.00% | 0.0% |
Q4 2020 | $36,000 | +200.0% | 2,080 | +186.5% | 0.00% | +33.3% |
Q3 2020 | $12,000 | +71.4% | 726 | +132.7% | 0.00% | +50.0% |
Q2 2020 | $7,000 | – | 312 | +1460.0% | 0.00% | – |
Q1 2020 | $0 | – | 20 | +150.0% | 0.00% | – |
Q2 2019 | $0 | – | 8 | +14.3% | 0.00% | – |
Q4 2018 | $0 | – | 7 | +40.0% | 0.00% | – |
Q2 2018 | $0 | -100.0% | 5 | 0.0% | 0.00% | -100.0% |
Q1 2018 | $1,000 | – | 5 | 0.0% | 0.00% | – |
Q4 2017 | $0 | – | 5 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
CM Management, LLC | 50,000 | $160,000 | 0.18% |
TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |